Trial intelligence / Profile preview

Fulvestrant With or Without Capecitabine in ER+ Postmenopausal Breast Cancer After Endocrine Progression

ChiCTR-IPR-16008926Phase 4Not yet recruiting

Sponsor

Department of Endocrine and Breast Surgery, First Affiliated Hospital of Chongqing Medical University

Start

Aug 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1